Barclays Maintains Overweight on RadNet, Lowers Price Target to $65
RadNet, Inc. (RDNT) Q1 2026 Earnings Call Transcript
RadNet Raises FY2026 Sales Guidance from $2.460B-$2.520B to $2.490B-$2.550B vs $2.456B Est
RadNet Q1 Adj. EPS $(0.28) Misses $(0.19) Estimate, Sales $575.631M Beat $557.971M Estimate
RadNet Forms JV With Saint Alphonsus Health System In Idaho To Operate Three Multimodality Outpatient Imaging Centers
Barclays Maintains Overweight on RadNet, Lowers Price Target to $70
3 Undervalued Stocks Estimated To Be 30.8% To 45.3% Below Intrinsic Value
GE HealthCare, RadNet expand AI mammography collaboration
How The RadNet (RDNT) Story Is Evolving With AI, Capital Plans And Reimbursement Expectations
3 of Wall Street’s Favorite Stocks We Find Risky
U.S. Diagnostic Imaging Centers Industry Report 2025: Analysis of the $26 Billion Technology-driven and Fragmented Market with 6,900 Facilities
RadNet (RDNT): Buy, Sell, or Hold Post Q4 Earnings?
RadNet (NASDAQ:RDNT) Q4 Earnings: Leading The Testing & Diagnostics Services Pack
RadNet Deepens AI Ambitions With Gleamer Deal And Workflow Focus
RadNet (RDNT) Acquires Gleamer for €230 Million
RadNet Insider Sells 15,000 Shares as Stock Falls 12% in 2026
RadNet CFO Touts “Unprecedented” Volume Momentum, Sees Digital Health as 2026 Growth Engine
Why RadNet (RDNT) Shares Are Sliding Today
3 Russell 2000 Stocks That Concern Us
RadNet, Inc. to Present Today at the KeyBanc Capital Markets Healthcare Forum
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.